Eyelash Growth From Application of Bimatoprost in Gel Suspension to the Base of the Eyelashes
Eyelash Growth From Application of Bimatoprost in Gel Suspension to the Base of the Eyelashes
Objective: To determine if Lumigan (bimatoprost) causes increased lash length when used in
 gel suspension applied to the base of the eyelashes. Methods: Subjects recruited from the
 Bascom Palmer Eye Institute were screened and those who met inclusion criteria were enrolled.
 Each participant received two vials of gel suspension, which contained bimatoprost and normal
 saline, respectively, each mixed 1:1 with GonakTM gel and labeled "right eye" and "left eye"
 according to randomization. The suspension was applied to the eyelashes every evening on the
 designated eye for 6 weeks. Lash length was measured with a caliper at enrollment, at weekly
 intervals during the study and at 1 and 3 months after study completion. Visual acuity,
 ocular symptoms, intraocular pressure and photographs were documented at these same
 intervals. Results: The average eyelash growth in the Lumigan group was 2.01mm (vs. control
 average of 1.13mm) which was a statistically significant difference (p=0.009). The average
 intraocular pressure decreased equally in both groups (2.14 mmHg). No change in visual acuity
 or iris discoloration was noted in any of the subjects. Discussion: Our data showed an
 increase in eyelash length with use of Lumigan in gel suspension, suggesting that it may have
 eyelash lengthening properties.
Study completed
Inclusion Criteria:

 -  Age greater than 20 and less than 90 and patients who have previously used and are
 comfortable with applying mascara.

 Exclusion Criteria:

 -  History of glaucoma, uveitis, pregnancy, allergic reaction to prostaglandins or the
 gel suspension, alopecia, and previous usage of other eyelash growth enhancement.